Search

everythinglearnresearchcommunity

for

Search:↓

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Elderly skin care needs personalized treatment, early intervention, and integrated psychiatric care.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

A dog with a pituitary tumor developed tertiary hypothyroidism, improved with treatment, but was later euthanized due to neurological issues.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.